Transition From Estrogen–Progestin to Raloxifene in Postmenopausal Women: Effect on Vasomotor Symptoms

OBJECTIVE:To compare vasomotor symptoms after transition from estrogen–progestin therapy to raloxifene 60 mg/d with and without a placebo washout. METHODS:Postmenopausal women currently taking continuous combined estrogen–progestin therapy (conjugated equine estrogen, 0.625 mg/medroxyprogesterone ac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Obstetrics and gynecology (New York. 1953) 2004-02, Vol.103 (2), p.267-273
Hauptverfasser:	Gordon, Stephen, Walsh, Brian W, Ciaccia, Angelina V, Siddhanti, Suresh, Rosen, Amy S, Plouffe, Leo
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Analysis of Variance Biological and medical sciences Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Drug Combinations Estrogens, Conjugated (USP) - administration & dosage Female Follow-Up Studies Gynecology. Andrology. Obstetrics Hot Flashes - diagnosis Hot Flashes - drug therapy Humans Medical sciences Middle Aged Postmenopause - drug effects Postmenopause - physiology Probability Progestins - administration & dosage Raloxifene Hydrochloride - administration & dosage Reference Values Risk Assessment Severity of Illness Index Single-Blind Method Treatment Outcome Vasomotor System - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!